KEARSTON PERFETTO: Open Payments
NPI 1003045857 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 89 payments from 17 companies in 2025. Trend: 2023 $2,240 · 2024 $2,289 · 2025 $2,016
Food & beverage: $2,016
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $567 |
| AstraZeneca Pharmaceuticals LP | 16 | $293 |
| PFIZER INC. | 11 | $238 |
| Novo Nordisk Inc | 9 | $173 |
| Astellas Pharma US Inc | 7 | $136 |
| Lilly USA, LLC | 2 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $130 |
| Phathom Pharmaceuticals, Inc. | 6 | $79 |
| Amgen Inc. | 4 | $72 |
| Exact Sciences Corporation | 3 | $68 |
Products named: BREZTRI, QULIPTA, VRAYLAR, ELIQUIS, UBRELVY, Veozah, Kerendia, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
